Most CROs operate study-to-study.
But most clinical technology vendors price their platforms for enterprise portfolios.
The OpenClinica CRO Partnership Program aligns pricing, billing, and platform access with how small and mid-size CROs actually win work.
CROs delivering sponsor-facing clinical trials: Teams running regulated studies without enterprise portfolio leverage.
CROs operating study-to-study: Organizations that scope, price, and deliver trials one proposal at a time.
CRO leaders who want a technology partner, not just a vendor: Teams looking for aligned economics, platform expertise, and collaborative support.
Preferred pricing typically reserved for enterprise CRO agreements.
Platform costs begin when the study activates — not during the RFP process.
EDC, eConsent, eCOA/ePRO, Randomization, and analytics in one environment.
Use the platform for demos, proposal support, and internal training.
Co-branded materials and thought-leadership promotion with OpenClinica.
A consistent OpenClinica contact supporting your CRO team.
